SANOFI CONS HEALTHC IND L Share Price

SANOFI CONS HEALTHC IND L Share Price

NSE: SANOFICONR
|
Pharmaceuticals
|
S Cap
₹ 4,078.00
+₹88.50 (2.22%)
1D
Last updated 18 Sep, 2026, 15:29 IST

SANOFI CONS HEALTHC IND L Share Price Today

As of 18 Sep 2026, SANOFI CONS HEALTHC IND L share price is ₹4,078.00. The stock opened at ₹3,999.00, compared to its previous close of ₹3,989.50. During today's trading session, SANOFI CONS HEALTHC IND L share price moved in the range of ₹3,992.00 to ₹4,078.00, with an average price of ₹4,035.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,926.00 and a high of ₹5,357.00. On the performance front, SANOFI CONS HEALTHC IND L share price has declined by 5.08% over the last six months and is down 24.26% on a year-on-year basis.


₹3,992.00
2.22% up today
₹4,078.00
1D LOW
1D HIGH

SANOFI CONS HEALTHC IND L Returns Calculator


Circuit
L
H
₹3,191.60
₹4,787.40
52-week
L
H
₹3,926.00
₹5,357.00

About SANOFI CONS HEALTHC IND L

SANOFI CONS HEALTHC IND L Share Price
ISIN
INE0UOS01011
Sector Market Cap
₹ 9,229.75 Cr

Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.

SANOFI CONS HEALTHC IND L Financial Highlights

  • Revenue: SANOFI CONS HEALTHC IND L reported revenue of ₹896.80 crore in FY25 vs ₹896.80 crore in FY25. It showed an increase of 0.00% on a yearly basis.
  • Operating Profit: SANOFI CONS HEALTHC IND L reported an operating profit of ₹320.30 crore in FY25 vs ₹320.30 crore in FY25. It showed an increase of 0.00% on a year-on-year basis.
  • Net Profit: SANOFI CONS HEALTHC IND L reported a net profit of ₹240.10 crore in FY25 vs ₹240.10 crore in FY25. It showed an increase of 0.00% on a yearly basis.

SANOFI CONS HEALTHC IND L Quarterly Result Highlights

  • SANOFI CONS HEALTHC IND L reported revenue of ₹242.00 crore in Jun 2026, compared with ₹234.80 crore in Mar 2026, representing an increase of 3.07% on a quarter-on-quarter (QoQ) basis.
  • SANOFI CONS HEALTHC IND L reported an operating profit of ₹91.90 crore in Jun 2026, compared with ₹90.70 crore in Mar 2026, representing an increase of 1.32% on a quarter-on-quarter (QoQ) basis.
  • SANOFI CONS HEALTHC IND L reported a profit of ₹68.80 crore in Jun 2026, compared with ₹67.80 crore in Mar 2026, reflecting an increase of 1.47% on a QoQ basis.
  • The earnings per share (EPS) of SANOFI CONS HEALTHC IND L stood at ₹104.27 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
71.27%
FII
2.60%
Other DII
4.85%
Retail and other
8.27%
Mutual funds
13.01%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20252.94%
Dec 20252.83%
Mar 20262.76%
Jun 20262.60%
Mkt Cap Cr
9,219.04

P/E
42.27

P/B
35.83

ROE
77.82%

D/E
0.11

ROCE
92.58%

Div. Yield
1.37%

EPS(TTM)
104.27
Turnover
1.89

EV/EBITDA
30.28

Net Margin
27.33%

Op. Margin
38.02%

ROA
51.64%

Quick Ratio
3.37

Curr. Ratio
2.91
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Sanofi Consumer has not beaten FD return of 7%
Step 2 of 5
Valuation
Expensive
Sanofi Consumer PE is significantly higher than its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,47,716.0036.955.3613.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,48,120.0084.8314.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,86,038.0086.2922.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,13,451.0024.704.1818.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,858.0033.033.2211.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,05,707.0096.9519.9416.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories97,828.7030.732.5711.07%0.1812.54%377.950.68%0.4138.68
Aurobindo Pharma96,890.8026.112.569.25%0.1911.76%394.820.24%0.3841.58
Lupin95,660.0017.234.2623.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,793.9045.845.8211.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SANOFI CONS HEALTHC IND L Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsDec 2025Dec 2024Dec 2023
Revenue₹878.40₹724.50₹555.40
Other Income₹18.40₹13.00₹4.10
Total Revenue₹896.80₹737.50₹559.50
Total Expenses₹583.10₹462.30₹338.40
Profit Before Tax₹320.30₹246.80₹219.30
Tax₹80.20₹65.80₹54.40
Profit After Tax₹240.10₹181.00₹164.90
EPS - Basic₹104.27₹78.59₹71.60
EPS - Diluted₹104.27₹78.59₹71.60

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsDec 2025Dec 2024Dec 2023
Profit before tax₹320.30₹246.80₹219.30
Income before WC changes₹316.00₹247.30₹217.10
Change in Assets-₹52.40₹266.00-₹209.90
Change in Liabilities-₹1.40₹50.10-₹3.40
Change in WC-₹53.80₹316.10-₹213.30
Cash flow from Operations₹174.80₹439.00-₹0.40
Cash flow from Investing₹7.60₹1.90₹0.00
Cash flow from Financing-₹134.50-₹115.60₹2.00
Total Cash Flow₹47.90₹325.30₹1.60
Cash (Start of the year)₹326.90₹1.60₹0.00
Cash (End of the year)₹374.80₹326.90₹1.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsDec 2025Dec 2024Dec 2023
Non-Current Assets₹52.70₹39.60₹10.20
Current Assets₹494.30₹391.70₹335.20
Total Assets₹547.00₹431.30₹345.40
Current Liabilities₹128.40₹130.60₹129.90
Net Current Asset₹365.90₹261.10₹205.30
Non-Current Liabilities₹34.60₹27.70₹7.90
Equity Capital₹384.00₹273.00₹207.60
Total Equity & Liabilities₹547.00₹431.30₹345.40
* All values are in INR Crore
Qty
Bid
61
4033.4
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 61
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
28.73
Bearish

ATR (14)
116.32
Neutral

STOCH(9,6)
20.56
Bullish

STOCH RSI (14)
22.86
Neutral

ADX(9)
15
Bullish

UO(9)
40.7
Neutral

ROC(12)
-3.64
Bearish

WillR(14)
-83.09
Bullish
Period
Simple value
Exponential vaue

5D
4029.64
4024.58

10D
4078.64
4066.21

20D
4130.09
4144.91

50D
4378.61
4313.77

100D
4536.79
4412.1
Volume trend — traded volume by day
18 Sep0L
17 Sep0L
16 Sep0L
15 Sep0L
11 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SANOFI CONS HEALTHC IND L Share Price
SANOFI CONS HEALTHC IND L
Pharmaceuticals
Add Stock
Add Another

SANOFI CONS HEALTHC IND L Share Price FAQs












SANOFI CONS HEALTHC IND L share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837